What is Morgan Stanley's price target for OSH?

Morgan Stanley's latest stated price target for Oak Street Health Inc. (OSH) is $19, from its action on Mar 2, 2022.

What is Morgan Stanley's rating on OSH?

Morgan Stanley rates OSH Overweight, a bullish rating, as of Nov 14, 2022.

When did Morgan Stanley last change its view on OSH?

On Nov 14, 2022, Morgan Stanley upgrades to Overweight from Equal-Weight.

Morgan Stanley OSH price target and rating history

Oak Street Health Inc. (OSH) · Health Care

Morgan Stanley rates Oak Street Health Inc. (OSH) Overweight with a $19 price target, as of its latest action on Nov 14, 2022. It has published 6 rating actions on OSH since August 2021, including 1 upgrade and 2 downgrades.

Current rating: Overweight
Price target: $19
Median target, all firms: Too few
Actions on OSH: 6

Morgan Stanley price target on OSH

Morgan Stanley price target on OSH, each point a stated target, August 2021 to March 2022.

Every Morgan Stanley rating on OSH

Nov 14, 2022
UpgradeMorgan Stanley upgrades to Overweight from Equal-Weight
Mar 2, 2022
ReiterateMorgan Stanley raises its price target to $19 from $18, keeps Equal-Weight
Dec 17, 2021
DowngradeMorgan Stanley downgrades to Equal-Weight from Overweight, price target $44 to $33
Dec 16, 2021
DowngradeMorgan Stanley downgrades to Equal-Weight from Overweight
Nov 12, 2021
ReiterateMorgan Stanley cuts its price target to $44 from $60, keeps Overweight
Aug 31, 2021
ReiterateMorgan Stanley cuts its price target to $60 from $79, keeps Overweight

Questions about Morgan Stanley and OSH

What is Morgan Stanley's price target for OSH?: Morgan Stanley's latest stated price target for Oak Street Health Inc. (OSH) is $19, from its action on Mar 2, 2022.
What is Morgan Stanley's rating on OSH?: Morgan Stanley rates OSH Overweight, a bullish rating, as of Nov 14, 2022.
When did Morgan Stanley last change its view on OSH?: On Nov 14, 2022, Morgan Stanley upgrades to Overweight from Equal-Weight.

More OSH rating histories

All Morgan Stanley ratings OSH news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.